All posts by medical

What can at-home genetic tests tell you about heart-related risks? – Harvard Health

Published: June, 2020

About 30 million Americans have used direct-to-consumer genetic tests such as 23andMe and Ancestry. While some are simply curious about their ethnic heritage, many pay extra to learn about their propensity for certain diseases and conditions. But can the results tell you anything useful about your odds of developing heart disease, the nation's leading killer?

When it comes to coronary artery disease by far the most common form of heart disease the answer is maybe, says Dr. Pradeep Natarajan, director of preventive cardiology at Harvard-affiliated Massachusetts General Hospital. "Genetics are just one aspect of a person's risk. Lifestyle habits such as smoking, diet, and exercise play a bigger role," he says.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

Read more here:
What can at-home genetic tests tell you about heart-related risks? - Harvard Health

Genetic features pave way for targeted BPDCN therapies – Dermatology Times

Researchers are learning more about genetic aberrations common in the rare but clinically aggressive hematological cancer blastic plasmacytoid dendritic cell neoplasm. There is one targeted therapy approved by the U.S. Food and Drug Administration: Elzonris (tagraxofusp-erzs, Stemline). However, more treatment options are needed to improve the cancers clinical outcome, according to a review published May 2020 in Critical Reviews Oncology/Hematology.1

Dermatologists might be the first providers to encounter patients with blastic plasmacytoid dendritic cell neoplasm because more than 70% of these patients have cutaneous lesions. Those lesions often are asymptomatic and vary in size. The skin lesions tend to have nodules, plaques or bruise-like areas, a brown to violet color and might be solitary or multifocal, according to the authors.

Blastic plasmacytoid dendritic cell neoplasm often originates from type 2 myeloid-derived resting plasmacytoid dendritic cell precursors. Recent research suggests providers can diagnose the cancer when patients express at least four of five plasmacytoid dendritic cell specific markers, CD4, CD56, CD123, TCL1 and BDCA-2, without expressing myeloid, T-cell or B-cell lineage markers.

Commonly, [blastic plasmacytoid dendritic cell neoplasm] is characterized by high CD123 expression, aberrant NF-B [nuclear factor-B] activation, dependence on TCF4-/BRD4-network, and deregulated cholesterol metabolism, they wrote.

Despite advancing knowledge about the cancer type, patients median overall survival remains at 12 to 14 months, according to the paper. Conventional treatment approaches include chemotherapy, radiotherapy and ultimately hematopoietic stem cell transplantation. The challenges with conventional therapies are while blastic plasmacytoid dendritic cell neoplasm is sensitive to some chemotherapy regimens, patient relapse is high at more than 60%. And many patients with blastic plasmacytoid dendritic cell neoplasm are too old or frail to have intensive chemotherapy or hematopoietic stem cell transplantation, according to the authors.

Recently, the most attractive agent for [blastic plasmacytoid dendritic cell neoplasm] is tagraxofusp, which is composed of the catalytic and translocation domains of diphtheria toxin (DT) fused to interleukin-3 (IL-3), the authors wrote.

Blastic plasmacytoid dendritic cell neoplasm cells overexpress interleukin-3 receptor subunit alpha (IL3RA, also called CD123). Elzonris, or tagraxofusp-erzs, is a CD123-directed cytotoxin given intravenously, which is used to treat blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients 2 years and older.

Researchers reported in a study of 47 blastic plasmacytoid dendritic cell neoplasm patients published in 2019 in the New England Journal of Medicine that tagraxofusp led to clinical responses in untreated and relapsed patients.2 The overall response rate with tagraxofusp was 90% and the primary outcome of complete response and clinical complete response was 72% among the previously untreated patients. Overall response was 67% in the previously treated patients. Serious adverse events including capillary leak syndrome, hepatic dysfunction and thrombocytopenia were common, according to the NEJM paper.

More targeted therapies are needed to treat blastic plasmacytoid dendritic cell neoplasm, but many potential therapeutic agents are not advancing to clinical trials, according to authors of the paper in Critical Reviews Oncology/Hematology.

Common blastic plasmacytoid dendritic cell neoplasm characteristics are genetically heterogeneous and provide valuable drug targets, according to the authors.

Apart from aberrant activation of NF-B signaling pathway, which is highly dependent on TCF4- and BRD4- transcriptional networks, cholesterol metabolism deregulation and CD123 expression, defects of DNA damage repair and mitosis are new, potential common features of the cancer. Corresponding therapies might be promising, the authors wrote.

Venetoclax, anti-CD123 CAR-T, XmAb14045 and IMGN632 are in clinical trials for blastic plasmacytoid dendritic cell neoplasm. But the authors noted that bortezomib, lenalidomide, 5-aza and pralatrexate could easily be pushed to the front line of the cancers treatment.

Disclosures:

The authors report no relevant disclosures.

References:

1. Zhang X, Sun J, Yang M, Wang L, Jin J. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Crit Rev Oncol Hematol. 2020 May;149:102928.2. Pemmaraju N, Lane AA, Sweet KL, et al. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019;380(17):1628-1637.

Read more:
Genetic features pave way for targeted BPDCN therapies - Dermatology Times

Abortion does not need to be available across Northern Ireland – The Irish News

ABORTION activist Goretti Horgan (May 26) has failed to refute the public perception of Northern Irelands new abortion law as extreme.

She claims that the abortion regime, imposed over the heads of the Northern Ireland electorate by the UK Government, is not at all extreme.

However, she also admits that the ferocious new abortion law permits the termination of full-term babies.

We are told that there is nothing new about the new law allowing abortion up to birth.

Indeed, up to 20,000 babies are terminated in late-term abortions in Britain each year, according to Department of Health statistics.

The Irish Citizens Assemblys recommendations on abortion were treated as the holy grail by the Irish government and its pro-abortion allies.

Yet fierce criticism was rightfully directed at it in 2017 for its astounding bias in favour of thepro-abortion position.

The real citizens assembly in Northern Ireland consisted of tens of thousands of people who marched on Belfast city centre and at Stormont in record-breaking pro-life rallies in September 2019.

Additionally, an overwhelming 79 per cent of the 21,000 people who responded to the NIOs recent public consultation were opposed to the introduction of any form of abortion.

The consensus has never been clearer there is no public support for this abortion regime.

There have been attempts to justify the disability-selective abortion which is permitted under the new legislation, including on the basis that an embryo or foetus is not a person.

But this is so wrong that it is hard to know where to begin. An embryo or a foetus (the Latin phrase for little one) is just as much part of the human race as you or I.

Any embryology textbook will tell you that life begins at conception and a human foetus is just that human.

These are necessary, scientific stages of human development. How can anyone say that a developing unborn child is not a human being?

No, abortion does not need to be available across Northern Ireland.

Women and their children need hope, real support and life-affirming resources, not the death and destruction of abortion.

In an age of 4D ultrasound scans, and at a time when we are witnessing nations worldwide working to undo permissive abortion laws, we must follow the path of science, compassion and human rights, and protect unborn children.

BERNADETTE SMYTHPrecious Life

Using Celtic mythology to support pro-abortion views shows degree of desperation

Dr OBrien of Alliance for Choice (May 25) includes a mixture of fact and fable in her defence of abortion. That St Brigid performed the first recorded abortion in Ireland in 650AD is given as fact but no contextual detail is given for this assertion. The hagiography of St Brigid was written by Cogitosus around 650AD some 127 years after her death. One translation by Liam De Paor does mention that St Brigid caused the foetus to disappear, without coming to birth and without pain. This is not suggestive of an abortion, and indeed this text is not included in modern translations. From an historical critical viewpoint it seems unlikely that this event ever happened since the source is uncorroborated. Dr OBrien merely uses the saint for political purposes. Indeed, that she has to support her pro-abortion views using historical revisionism and Celtic mythology indicates a degree of desperation in her argument.

There is no doubt St Brigid in the Catholic and Christian tradition would have condemned direct abortion. From the earliest times the Church has always condemned wilful abortion as a moral evil. A careful reading of the early Church fathers teachings supports this.

Pope, Saint John Paul II often spoke of the anti-life mentality of our era that promotes a culture of death.Abortion is not health care. It leads to the intentional termination of a human being. In the classic Hippocratic Oath it states: I will neither give a deadly drug to anybody who asked for it, nor will I make a suggestion to this effect. Similarly I will not give to a woman an abortive remedy.Dr OBrien will do well to reflect on the wisdom of the ancients.

BOBBY FORRESTCrossgar, Co Down

Thank God the dark days are gone

My social media accounts have been flooded in recent days with happy memories of May 26 2018 when voters in the Republic of Ireland voted overwhelmingly to allow abortion in Ireland after decades of exporting the problem to England. It starkly exposed the anomaly that Northern Ireland remained the only place in the islands of Britain and Ireland where women could not avail of the human right to determine their own bodily autonomy. No more. After decades of campaigning the Bill allowing Abortion in Northern Ireland finally came into line on March 31. We are still waiting for the regulations to go through final checks after the public consultation on the implementation of the bill but, have no doubt, we are not going back. Gone are the dark days when people of all religions, and none, and from every social status helped women out in dreaded secrecy to travel for abortions.Finally, our young people have a chance for a future not determined by private religious beliefs.I welcome fulsomely the changes that were hard fought for and thank all who brought them about.

MARGO HARKINDerry City

Do you dig it?

I suspected the lockdown was about to lift a few weeks ago when the Lisburn Road in Belfast was coned off and the digging began. This was reminiscent of the first week in September when the dig usually heralds weeks of disruption for the new term. The current dig is to replace street lights with new but identical poles. Even if this was necessary, surely the old poles could have been removed at the same time. Perhaps that is the next dig. With statistics showing Belfast to be the second in the league table of UK dug up cities surely it is time for some strategic oversight.

Of course theres a cycle lane coming soon but thats a deeper dig into the public purse.

NOEL PHOENIXBelfast

Still waiting

Almost the whole of page14 of The Irish News (May 26) was given over to Goretti Horgans pro-abortion views. There are two sides to this argument and I looked at the opposite page for the opposing argument.

I looked in vain. I told myself a balancing article will surely appear the following day, or the day after that, or the day after that...

Guess what ? Im still waiting.

E DOOHANDerry City

Read the original post:
Abortion does not need to be available across Northern Ireland - The Irish News

New physicians coming to the northeast – northeastNOW

The town of Tisdale is also set to welcome a new physician.

Dr. Omotayo Abiara will provide services out of the Northeast Medical Clinic in Tisdale, starting Monday, June 15.

Dr. Abiara is from Nigeria, and earned her Bachelor of Medicine, Bachelor of Surgery at the University in Ibadan, Nigeria.

She also holds a Masters Degree in clinical embryology from the University of Leeds, United Kingdom.

The SHA said in its news release Dr. Abiara has more than 10 years of experience as a family physician and general medical practitioner, and has a special interest in womens health.

Patients looking for a family physician can call Northeast Medical Clinic at 306-873-4561 to have their patient files transferred, and to make an appointment.

Editors note: this article was amended to correct the phone number initially given for the Porcupine Medical Clinic.

cam.lee@jpbg.ca

On Twitter: @camlee1974

Read the original here:
New physicians coming to the northeast - northeastNOW

Using neuroscience to banish presenteeism from the financial sector – Bobsguide

Presenteeism is a deep-rooted issue in financial organisations, with a drastically negative impact on personal wellbeing and billions of pounds worth of impact on the UK economy. Employees who are physically present but are unable to work at full capacity because of poor mental health are shadows of themselves. And often the issue stems from depression, stress, incessant worry or insomnia all conditions which employers can prevent occurring if the right measures are taken.

It may be seen as a buzzword but Deloitte estimates presenteeism costs the UK up to 29bn per year, outweighing the 8.6bn turnover costs of poor mental health or the 6.8bn cost in increased absence. In March, the CIPD, the human resources professionals association published a report that found 89 percent of respondents recognised presenteeism in their organisation.

Financial institutions are of course infamous for a results-driven culture which can be a spur to great success as well as a source of psychological pressure and poor mental wellbeing. This is why organisations like the City Mental Health Alliance exist.

Unfortunately, presenteeism shows few signs of abating in most cases because organisations have failed to realise new science-based tools and techniques are available to prevent it. In a very recent study of 500 city employees working from home during the current lockdown, Deloitte found 44 per cent said wellbeing tools would help them, but only 35 percent actually use such tools. The CIPD found only 32 percent of HR professionals with presenteeism in their organisation had done anything to reduce it.

One of the problems is acceptance of the problem at the top of organisations and another is the poor nature of many conventional tools on offer, which are unengaging and only offer help when it is too late. The conventional, reactive model has proved itself inadequate and must be replaced with a proactive paradigm.

Where there is an understanding of mental health at senior level, we see greater action and the provision of wellbeing programmes for the workforce. If the wellbeing tools are designed with great care and based on neuroscience and the latest evidence-based techniques, that in turn stimulates uptake.

A unique neuroscience-based platform that offers workforces bespoke content, tools and evidence-backed techniques can head off stress, sleeplessness and the causes of presenteeism before they develop. Employees can use almost any device to access advice on staying mentally fit, using nutrition, exercise, stress and anxiety-relieving techniques, cognitive behavioural therapy, yoga, mindfulness and more. Online, company-wide communities enable employees to share concerns which may range from childcare and maternity to chronic pain.

Employees using these programmes have the opportunity to benchmark using neuroscience-based psychometric tests and then progress towards resilience goals they set themselves. Employers can then view this anonymised engagement data and better understand their workforces needs and enables them to see the value of what they are providing.

Results and return on investment are of course important and this must be viewed with consideration to the business cost of struggling employees. Deloitte estimates the annual cost per employee of poor mental health in the financial sector to be as much as 3,300 per annum. Theres also the cost of employees suffering from presenteeism which is impossible to calculate but is known to have a significant impact of the levels of vitality and innovation within a company.

Deloitte also analysed the ROI on different types of employee mental health programmes. It found proactive, preventive programmes offer an average ROI of 5:1, compared with the mere 3:1 of reactive models that offer interventions when employees are already suffering. Programmes with early stage activities and bespoke web portals produce a return of 6:1.

The evidence of what works is growing. Financial institutions need to recognise there has been a major shift in workplace wellbeing founded on proactive intervention to keep employees mentally fit and resilient. Banks, insurers, accountancy practices and law firms may hand out gym memberships as perks to improve employee fitness, but mental wellbeing and resilience programmes are even more essential. They keep entire organisations fit and free of presenteeism, using neuroscience and evidence-based techniques so a workforce is more fulfilled, more focused and more productive.

See more here:
Using neuroscience to banish presenteeism from the financial sector - Bobsguide

30,000-cell Study Maps the Development of Sound Sensing in the Mouse Inner Ear – Technology Networks

A team of researchers has generated a developmental map of a key sound-sensing structure in the mouse inner ear. Scientists at the National Institute on Deafness and Other Communication Disorders (NIDCD), part of the National Institutes of Health, and their collaborators analyzed data from 30,000 cells from mouse cochlea, the snail-shaped structure of the inner ear. The results provide insights into the genetic programs that drive the formation of cells important for detecting sounds. The study also sheds light specifically on the underlying cause of hearing loss linked to Ehlers-Danlos syndrome and Loeys-Dietz syndrome.

The study data is shared on a unique platform open to any researcher, creating an unprecedented resource that could catalyze future research on hearing loss. Led by Matthew W. Kelley, Ph.D., chief of the Section on Developmental Neuroscience at the NIDCD, the study appeared online in Nature Communications(link is external). The research team includes investigators at the University of Maryland School of Medicine, Baltimore; Decibel Therapeutics, Boston; and Kings College London.

Unlike many other types of cells in the body, the sensory cells that enable us to hear do not have the capacity to regenerate when they become damaged or diseased, said NIDCD Director Debara L. Tucci, M.D., who is also an otolaryngology-head and neck surgeon. By clarifying our understanding of how these cells are formed in the developing inner ear, this work is an important asset for scientists working on stem cell-based therapeutics that may treat or reverse some forms of inner ear hearing loss.

In mammals, the primary transducers of sound are hair cells, which are spread across a thin ribbon of tissue (the organ of Corti) that runs the length of the coiled cochlea. There are two kinds of hair cells, inner hair cells and outer hair cells, and they are structurally and functionally sustained by several types of supporting cells. During development, a pool of nearly identical progenitor cells gives rise to these different cell types, but the factors that guide the transformation of progenitors into hair cells are not fully understood.

To learn more about how the cochlea forms, Kelleys team took advantage of a method called single-cell RNA sequencing. This powerful technique enables researchers to analyze the gene activity patterns of single cells. Scientists can learn a lot about a cell from its pattern of active genes because genes encode proteins, which define a cells function. Cells gene activity patterns change during development or in response to the environment.

There are only a few thousand hair cells in the cochlea, and they are arrayed close together in a complex mosaic, an arrangement that makes the cells hard to isolate and characterize, said Kelley. Single-cell RNA sequencing has provided us with a valuable tool to track individual cells behaviors as they take their places in the intricate structure of the developing cochlea.

Building on their earlier work on 301 cells, Kelleys team set out to examine the gene activity profiles of 30,000 cells from mouse cochleae collected at four time points, beginning with the 14th day of embryonic development and ending with the seventh postnatal day. Collectively, the data represents a vast catalog of information that researchers can use to explore cochlear development and to study the genes that underlie inherited forms of hearing impairment.

Kelleys team focused on one such gene, Tgfbr1, which has been linked to two conditions associated with hearing loss, Ehlers-Danlos syndrome and Loeys-Dietz syndrome. The data showed that Tgfbr1 is active in outer hair cell precursors as early as the 14th day of embryonic development, suggesting that the gene is important for initiating the formation of these cells.

To explore Tgfbr1s role, the researchers blocked the Tgfbr1 proteins activity in cochleae from 14.5-day-old mouse embryos. When they examined the cochleae five days later, they saw fewer outer hair cells compared to the embryonic mouse cochleae that had not been treated with the Tgfbr1 blocker. This finding suggests that hearing loss in people with Tgfbr1 mutations could stem from impaired outer hair cell formation during development.

The study revealed additional insights into the early stages of cochlear development. The developmental pathways of inner and outer hair cells diverge early on; researchers observed distinct gene activity patterns at the earliest time point in the study, the 14th day of embryonic development. This suggests that the precursors from which these cells derive are not as uniform as previously believed. Additional research on cells collected at earlier stages is needed to characterize the initial steps in the formation of hair cells.

In the future, scientists may be able to use the data to steer stem cells toward the hair cell lineage, helping to produce the specialized cells they need to test cell replacement approaches for reversing some forms of hearing loss. The studys results also represent a valuable resource for research on the hearing mechanism and how it goes awry in congenital forms of hearing loss.

The authors have made their data available through the gEAR portal(link is external) (gene Expression Analysis Resource), a web-based platform for sharing, visualizing, and analyzing large multiomic datasets. The portal is maintained by Ronna Hertzano, M.D., Ph.D., and her team in the Department of Otorhinolaryngology and the Institute for Genome Sciences (IGS)(link is external) at the University of Maryland School of Medicine.

Single-cell RNA sequencing data are highly complex and typically require significant skill to access, said Hertzano. By disseminating this study data via the gEAR, we are creating an encyclopedia of the genes expressed in the developing inner ear, transforming the knowledge base of our field and making this robust information open and understandable to biologists and other researchers.

This news release describes a basic research finding. Basic research increases our understanding of human behavior and biology, which is foundational to advancing new and better ways to prevent, diagnose, and treat disease. Science is an unpredictable and incremental process; each research advance builds on past discoveries, often in unexpected ways. Most clinical advances would not be possible without the knowledge gained through basic research.

Reference: Kolla, L., Kelly, M. C., Mann, Z. F., Anaya-Rocha, A., Ellis, K., Lemons, A., Palermo, A. T., So, K. S., Mays, J. C., Orvis, J., Burns, J. C., Hertzano, R., Driver, E. C., & Kelley, M. W. (2020). Characterization of the development of the mouse cochlear epithelium at the single cell level. Nature Communications, 11(1), 116. https://doi.org/10.1038/s41467-020-16113-y

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Read more:
30,000-cell Study Maps the Development of Sound Sensing in the Mouse Inner Ear - Technology Networks

Pattern Recognition and The Neuroscience of Beauty – Daily Times

Quite simply, humans are amazing pattern-recognition machines. They have the ability to recognize many different types of patterns and then transform theserecursive probabalistic fractalsinto concrete, actionable steps. If youve ever watched a toddler learn words and concepts, you can almost see the brain neurons firing as the small child starts to recognize patterns for differentiating between objects. Intelligence, then, is really just a matter of being able to store more patterns than anyone else. Once IBM could build machines that could recognize as many chessboard patterns as a chess grandmaster, the machines became smarter than humans.

However, studies from neuroscience and evolutionary biology challenge this separation of art from non-art. Human neuroimaging studies have convincingly shown that the brain areas involved in aesthetic responses to artworks overlap with those that mediate the appraisal of objects of evolutionary importance, such as the desirability of foods or the attractiveness of potential mates. Hence, it is unlikely that there are brain systems specific to the appreciation of artworks; instead there are general aesthetic systems that determine how appealing an object is, be that a piece of cake or a piece of music.

We set out to understand which parts of the brain are involved in aesthetic appraisal. We gathered 93 neuroimaging studies of vision, hearing, taste and smell, and used statistical analyses to determine which brain areas were most consistently activated across these 93 studies. We focused on studies of positive aesthetic responses, and left out the sense of touch, because there were not enough studies to arrive at reliable conclusions.

Theresultsshowed that the most important part of the brain for aesthetic appraisal was the anterior insula, a part of the brain that sits within one of the deep folds of the cerebral cortex. This was a surprise. The anterior insula is typically associated with emotions ofnegativequality, such as disgust and pain, making it an unusual candidate for being the brains aesthetic center. Why would a part of the brain known to be important for the processing of pain and disgust turn out to the most important area for the appreciation of art?

Beauty is defined in relation to the subject since it is a property that lies in the beholder. That is to say, the feeling of pleasure provoked by beauty in the subject is the only thing that justifies our speaking of it. Taste takes place in the conformity between the object and the faculties of the mind. Research on how the feeling of pleasure is produced in the subject leads one to consider that there must be an organ capable of perceiving beauty. Both the organ and its aesthetic sense were calledtaste. The experiences of taste would be immediate and spontaneous and would not be directly related to reason but rather to the realm of sensibility. From this point of view, an object is said to be beautiful because certain properties of the object stimulate our sensibility and make us feel its beauty.

In this sense, Hume discards the metaphysics of the beautiful but does not invalidate an empirical science of the aesthetic phenomenon. In fact, he believes that there must be rules in the arts that allow us to judge them.

Read this article:
Pattern Recognition and The Neuroscience of Beauty - Daily Times

Millions have been invested in the emerging field of neurolaw. Where is it leading? – ABA Journal

Feature

By Kevin Davis

June 1, 2020, 12:05 am CDT

Photo Illustration by Sara Wadford/Shutterstock

Robert Hauser, a criminal defense attorney in suburban Chicago, was hired by a man charged with shooting his wife after she berated him for leaving a coffeepot on all day. After firing four shots from a revolver, Larry Lotz called 911 and told the dispatcher what hed done. His wife, Karen, 59, died later at the hospital.

The criminal case against Lotz came down to two fundamental questions: Was he mentally stable when he shot her, and to what extent should he be held accountable under the law?

Larry Lotz. Photo courtesy of Illinois Department of Corrections

Lotz, a retired information technology professional and Vietnam vet who lived in Barrington, Illinois, was 65 years old at the time of his arrest in 2016. His friends and family could not believe Lotz would intentionally kill the woman he loved so dearly. Hauser says his client was not in his right mind, and he planned to argue that Lotz was temporarily insane, suffering from PTSD as well as showing early signs of Alzheimers disease.

Why would someone shoot someone they adored? Hauser asks. You dig into the mans background, and you can see no reason why. People thought it must be some kind of mistake. There had not been one instance of abuse in 40 years of marriage.

Hauser says he consulted with expert witnesses, including a doctor who ordered a positron emitted tomographyor PETscan to measure activity in Lotzs brain. Hauser says the images showed signs of dysfunction and evidence of Alzheimers. That brain scan, Hauser reasoned, could support his insanity defense.

The case raised a host of legal questions both old and new: How do courts determine a persons mental state and apply that in deciding guilt or innocence? How do judges and juries weigh evidence related to brain functioning? And what do lawyers and judges need to know to effectively evaluate such questions?

With a $4.85 million grant to Vanderbilt University in 2011, the Chicago-based MacArthur Foundation launched the Research Network on Law and Neuroscience with the mission to design and conduct brain-scanning experiments relevant to key topics in criminal justice, focusing on three themes: mental states, adolescent development and evidence. This funding amplified the foundations preliminary investment in an earlier exploratory initiative called the Law and Neuroscience Project.

Whats going on in a persons brain is relevant to so many domains of law, says Owen Jones, director of the research network and the Glenn M. Weaver, M.D., and Mary Ellen Weaver Chair in Law, Brain and Behavior at Vanderbilt Law School.

Owen Jones: Whats going on in a persons brain is relevant to so many domains of law. Photo by Sandy Campbell Photography for Vanderbilt University

Historically, theres been no way to make those assessments, Jones adds. When youre trying to understand the multiple causes of a persons behavior, you want to try to understand whats giving rise to their mental states.

Between 2005 and 2015, there were more than 2,800 judicial opinions in which criminal defense lawyers used or cited neuroscience to help mitigate or explain their clients behavior, according to a review co-authored by Duke University law professor Nita Farahany and Stanford Law School professor Henry T. Greely.

Given this growing use of neuroscience, Laurie Garduque, director of criminal justice with the MacArthur Foundation, says the foundation wanted to take a deeper look at how neuroscience might have an impact on criminal law. Part of the underpinnings of the network was to figure out whats relevant to the rule of law and the practice of law, she explains. We felt that it was really important, given the impact of the criminal justice system on society.

With MacArthur Foundation support ultimately reaching $7.6 million, the networkwhose members include judges and academics in various fieldshas produced scores of papers, books and articles, and it has hosted educational seminars around the country that have shed light on this burgeoning field known as neurolaw, Jones says.

The lawyer representing Lotz contended his client lacked the capacity to appreciate the criminality of his actions and suffered from a mental disease or defect at the time. You could see there was something definitely wrong, Hauser says.

His argument points to a crucial element of criminal law: The accused must have knowledge and intent to commit a crime to be considered responsible. But the law assigns varying degrees of culpability based on a persons mental statedistinguishing whether a person acted intentionally, recklessly or even negligently. Such distinctions may be difficult for judges and juries to discern, which makes assigning guilt and punishment even trickier.

Among the studies designed by the MacArthur group was one examining whether brain scans could reveal when someone was acting knowledgeably or recklessly. Researchers from Yale University and Virginia Tech asked 40 study participants to imagine they were carrying a suitcase through a security checkpoint. In some cases, the participants were told the suitcase they were carrying contained contraband. Others did not know what was inside but knew there was a risk the suitcase might contain something illegal. They also were told theyd be financially rewarded for successfully sneaking in contraband but punished with a fine if caught.

The study participants made these choices while lying inside an fMRI (functional magnetic resonance imaging) scanner, which measures changes in blood flow and oxygenation in the brain. This allows researchers to see which areas are active at specific times. On the basis of the scan results, which were run through a machine-learning program, the researchers could predict which subjects knew they were carrying contraband through security (knowledgeably) and which were aware only of a risk (recklessly) when they carried the suitcase through.

The study, published in 2017, showed the researchers could identify certain patterns of brain activity associated with making knowledgeable choices about criminal activity as opposed to reckless ones. The findings lend scientific support to the laws distinction between these two mental states, which determine how a person is charged and sentenced for a crime.

Although the initial study offers some insights, its much more difficult to assess knowledge or recklessness in the real world, says Gideon Yaffe, a professor of jurisprudence, of psychology and of philosophy at Yale Law School and one of the studys authors.

Fact-finders probably dont make those distinctions as cleanly as they should, and they have very little by way of expert, useful advice about how various conditions, such as mental disorders, affect those boundaries, Yaffe says. You cant always infer what their mental states are from their behavior when their mental states are shaped and conditioned by mental illness.

How might such research translate in the criminal justice system? There is a question of whether we have the right boxes, the right categories for responsibility, Yaffe says. And I think neuroscience can help us get confidence in the categories we have or reason to revise the categories we have.

Lotzs account of shooting his wife would be key in how attorneys would argue over his culpability. How accurate were his memories about the shooting, and was he telling the truth?

A patient prepares for an fMRI scan. Photo by Janne Moren;

Memory plays a vital part in the law, whether it relates to the reliability of eyewitness testimony or how defendants describe their state of mind. The MacArthur group has been investigating whether neuroscience can detect brain activity connected to memorieswhether its possible to distinguish between real and false memories and between truth and deception.

While private companies have promoted fMRI technology for lie detection, and some lawyers have attempted to present it, courts have not admitted such evidence, noting the technology has not achieved general acceptance in the scientific community.

Anthony Wagner, a professor of psychology and neuroscience and director of the Memory Lab at Stanford University, was among members of the MacArthur group who reviewed the literature on fMRI lie detection. Although he concluded its not ready for the courtroom, Wagner and his colleagues have been investigating whether its possible through brain scanning to detect when someone is experiencing a memory, a concept that someday might serve as another way to determine truthfulness.

Anthony Wagner: When someone has a false memory, the patterns are pretty similar to those of a true memory. Photo courtesy of Anthony Wagner

Wagners team has demonstrated that brain scan data can be used to detect when someone is experiencing a memory while looking at photos of people or places theyve seen before, compared with photos that are new to them. The algorithm they designed has been able to detect the presence of memories with 75%-95% accuracy.

In one study in 2016, Wagner recruited a group of Stanford students who wore digital cameras around their necks for three weeks, recording thousands of images as they walked around campus, went to class and went about their lives.

Afterward, the participants laid down in a scanner to view pictures, some collected from the cameras they wore and some from other students cameras. Using advanced statistical tools, the researchers found that certain patterns of brain activity could reveal whether the subject recognized photos from their past versus images from someone elses camera. The machine-learning algorithms were correct more than 90% of the time. They were remarkably accurate, higher than I was expecting for certain classifications, Wagner says. He stresses, though, that other classifications failed or were close to chance.

While detecting the presence of memories from cooperative test subjects has proved possible, Wagner and his colleagues wanted to know whether someone could intentionally hide a memory. A 2015 study found that with some coaching, people could obscure brain patterns associated with memory, leading to a failure to detect the presence of actual memories.

The upshot is that fMRI-based memory detection has limitations. When someone has a false memory, the patterns are pretty similar to those of a true memory, Wagner says. So in the lab, if people mistakenly believe they have seen a face before, the patterns are so similar to true memories that the ability to distinguish the two is barely above chance.

Theoretically, lawyers or law enforcement officers might someday employ fMRI scanners while having defendants look at photos of crime scenes or crime victims to see whether they trigger brain activity associated with memories.

Wagner notes the research is still in its nascent stage, far from being used in legal settings. Im very cautious when it comes to application where the stakes really matter. In a legal setting, the freedom and liberty of a defendant might be at stake; similarly, reaching a just outcome for a victim is important, and it would be a travesty if unproven brain technology were to lead to an unjust outcome, he says.

In court, we are asked to remember complex events that occurred as individuals were navigating their lives. In the lab, memory is often examined in more controlled and very limited conditions.

Although detecting memories and lies through brain scanning is still a long way from reaching the courtroom, neuroscience has offered a better understanding of the adolescent brain. The research has been used to support juvenile justice reform efforts, including raising the age at which children can be tried as adults and in determining the severity of sentencing them for murder convictions.

BJ Casey, a professor of psychology at Yale and a member of the MacArthur research group, is among the foremost experts on juvenile brain development. Her research was included in amicus briefs submitted to the U.S. Supreme Court to bolster arguments that the immature brains of juveniles are reason to exempt them from the death penalty (Roper v. Simmons, 2005) and mandatory life in prison (Graham v. Florida, 2010; and Miller v. Alabama, 2012). Although the court did not specifically cite neuroscientific research in its decisions, the justices did put an end to such penalties and sparked discussions about when a person should be considered an adult under the law.

BJ Casey: When youre under threat and under stress, its like taking your whole prefrontal cortex offline. Photo by Meredith Wright

The problem, Caseywho also serves as the director of Yales Fundamentals of the Adolescent Brain labargues, is that much of the discussion about brain maturity has been oversimplified. Brain development isnt linear, and it involves many dynamic changes and variables that confound easy explanations of behavior, impulsivity and recklessness among young people.

For example, the conventional wisdom is that juveniles are reckless and impulsive because their brains are not fully developed, particularly the prefrontal cortex. But Casey has found that younger children dont act as recklessly as adolescents, and that adolescents, even those around 12 to 13 years old, can be quite good at making decisions.

Its not like you magically have the brain of an adult on your 18th birthday, Casey says. The old model assumes that at age 18, we have full adult capacity. But what we show is that in emotional situations, young peoplethose 18 to 21 act more like teens in the activation in their brains and their performance than they do adults.

Casey has spent years researching what triggers young people and young adults to make poor decisions. It turns out that stress and pressure are among the biggest factors. When youre under threat and under stress, its like taking your whole prefrontal cortex offline, she says. So you can imagine engaging in behaviors that you otherwise might not be engaged in.

However, young people can make smart decisions in many situations.

Individuals can have a lot of self-control, but in certain contexts, they dont, Casey says. Thats why no one treatment or sentence fits all in the criminal justice system.

That means judges must carefully weigh the options. Young adults still should be held accountable. We may not want to put them in a juvenile facility, but we may want to consider that in terms of how theyre held accountable and how they get back into the community, because were still trying to set up their identity, Casey says.

Judges, lawyers and law students across the country have been learning more about the intersection of law and neuroscience in large part thanks to Francis Shen, a scholar, researcher and educator. Hes a professor at the University of Minnesota Law School, where he runs the Shen Neurolaw Lab and is executive director of education and outreach for the MacArthur Foundation Research Network on Law and Neuroscience.

Shen has been working with Jones to explain what neuroscience can and cannot do in the legal context.

Were not in the business of trying to sell our wares or to promote neuroscience in the courtroom but to focus on those things that are known and acknowledge those things that are unknown, Shen says. We try to engage in dialogue and open up a conversation about where this might be useful in your work. I think theres been an increasing amount of interest. We also have presented things very cautiously, identifying the various flaws.

Shen created his neurolaw lab to bridge science and law in a meaningful way and explore new ways of thinking. If theres one thing Id like to do with my lab, it is to communicate with the legal community that the brain is really this important, he says. Every story is a brain story. If you get that far, then to me, all the questions that law asks get reshapedin some formas brain [questions].

The essence of neuroscience and law, Shen says, is that deep human interpersonal connections define us and define what we care about. These are the things the legal system is ultimately protecting: protecting privacy, wanting to ensure safety and security and liberty, he says.

Francis Shen: We have to show some victories to show that neuroscience matters to law in a meaningful way. Photo by Zack Smith

In addition to teaching law at Minnesota and working with MacArthur, Shen is executive director of the Center for Law, Brain & Behavior at Massachusetts General Hospital in Boston, where he continues to promote the responsible and well-informed use of neuroscience. He believes such work can, and will, be relevant to lawyers. It can play a role that aids justice and produces a better world for having considered neuroscience, he says.

One of the most challenging questions is how lawyers can responsibly use neuroscience in the courtroom. Scientists conduct studies using groups of people to measure phenomena, while trials are focused on individuals and their behavior. Can the results of a study that demonstrates, for example, people with brain injuries often lose impulse control be applied to one person? In many cases, they cant, because not all people with brain injuries commit crimes.

Our work tried to move away from focusing on individual defendants to try to find things that are more broadly true about the promise and limitations of this technology in understanding how human brains work, Jones says.

Stephen Morse, a professor of law and of psychology and law in psychiatry at the University of Pennsylvania, has devoted considerable scholarship to the melding of law and neuroscience. Morse has been among the most renowned cautious voices in the field, arguing that neuroscientific research and imaging techniques are not poised to change the law in any significant way, and he is doubtful it canat least in the near future.

Neuroscience doesnt answer lifes questions. Lifes questions are normative, he says, adding that its highly unlikely any neuroscience finding would reach normative conclusions that would apply to the law.

Moreover, Morse says neuroscience hasnt moved the needle much in offering legally relevant evidence about human behavior. He says lawyers should not make inferences about behavior that the science does not support. For example, mental disorders are not defined by brain scans but by observable behavior and clinical testing. The problem is translation. Law is about reason-giving, Morse says.

Still, Morse says he was impressed with the findings of the knowledge and recklessness study because it shows promise. It made modest but serious progress, he says. We showed, as a proof of concept, that you might be able to find neuro correlates that would distinguish between two folk psychological states of mind, namely knowledge and recklessness.

Shen is also encouraged by that study and echoes Morses caution. We have to show some victories to show that neuroscience matters to law in a meaningful way, Shen says. If the claim is that advances in the understanding of our brain should lead to better outcomes in the law, then we have to show that its demonstrably true. As a field, we havent done that yet. The challenge is that neuroscience, in a lot of places, isnt ready.

At Lotzs murder trial, his state of mind was central to his defense. Dr. Geeta Bansal, a psychiatrist, testified that Lotz had post-traumatic stress disorder caused by childhood abuse and his service in Vietnam. She also said he had cognitive degeneration of his brain, a diagnosis that was bolstered by the images she found in a PET scan of his brain. Bansal concluded Lotz lacked the capacity to understand his actions at the time he shot his wife and fit the criteria for insanity.

Under cross-examination, however, Bansal noted that Lotz had the presence of mind to call 911, tell the dispatcher how many times he shot his wife and offer a detailed confession of the incident. Assistant States Attorney Scott Hoffert called Lotzs insanity defense ludicrous and described the case as an intentional, deliberate act fueled by anger.

Lotz had waived a trial by jury, preferring the case rest in the hands of Lake County Circuit Judge Daniel Shanes. The judge rejected Lotzs insanity defense, calling the killing of his wife an act of blind rage, and found him guilty of second-degree murder. Hanes, who said he considered Lotzs mental health issues and remorse, sentenced him to 16 years in prison.

Although disappointed with the verdict, defense attorney Hauser says he hopes his client can receive the mental health treatment he needs. Im happy he was found guilty of second-degree murder. He will only serve 50% of the sentence, and with other credits, he should be released in approximately seven years, Hauser says. With the second-degree finding, his life is not over.

While neuroscience did not play a central role in Lotzs trial, the issues raised in his case will continue to fuel future research as lawyers, scholars and scientists seek to better understand the connections among our brains, behavior and mental states.

Jones says although great mysteries about the brain remain, neuroscience has opened a window that already is having an impact on the law and legal scholarship. Weve long been comfortable thinking that the brains operations are unknowable, but in fact, theyre increasingly knowable, and lawyers on both sides will often want to pay more attention to this because there can be information available that is relevant to our clients, he says.

Lawyers interested in learning more can visit the networks website, which offers a portal to research articles and online resources. Jones is one of the authors of the pioneering textbook Law and Neuroscience, the second edition of which is scheduled for publication this year. Law and neuroscience classes are taught in at least 20 schools, Jones says.

The ABA Section of Science & Technology Law has been watching these developments, and it partnered with the MacArthur Foundation to sponsor The Future of Law and Neuroscience conference in Chicago in 2013. Eric Drogin and Carol Williams, co-chairs of the sections Committee on Behavioral and Neuroscience Law, agree that while the research is exciting, its far from solving age-old legal problems. Theyre not there yet, Drogin says. There is much to discuss, but at this point a lot of it is merely speculative.

Jones agrees the science is not ready for the courtroom, but he believes the research has been valuable. Despite all the progress thats been made, it still feels very much like a frontier, he says. I think the lawyers that are coming up through training right now, some of whom will or will not be learning about this, at least will be entering a world in which it is considered entirely unshocking that brain evidence is being offered.

Garduque believes the network has made great strides, notably its work on adolescent brain development and in educating the legal community about how neuroscience can be misunderstood and misused. Were quite proud of how it has helped and contributed to establishing a field, she says. There is still a great deal of work that needs to be done.

This article appeared in the June/July 2020 issue of the ABA Journal under the headline: Brain Matters: Millions have been invested in the emerging field of neurolaw. Where is it leading?.

Originally posted here:
Millions have been invested in the emerging field of neurolaw. Where is it leading? - ABA Journal

Researchers Identify Where Stress "Lives" in the Brain – Technology Networks

Yale researchers have found a neural home of the feeling of stress people experience, an insight that may help people deal with the debilitating sense of fear and anxiety that stress can evoke, Yale researchers report in the journal Nature Communications.Brain scans of people exposed to highly stressful and troubling images such as a snarling dog, mutilated faces or filthy toilets reveal a network of neural connections emanating throughout the brain from the hippocampus, an area of the brain that helps regulate motivation, emotion and memory.

The brain networks that support the physiological response to stress have been well studied in animals. Activation of brain areas such as the hypothalamus triggers production of steroid hormones called glucocorticoids in the face of stress and threats. But the source of the subjective experience of stress experienced by people during the COVID-19 pandemic, for instance, has been more difficult to pinpoint.

We cant ask rats how they are feeling, said Elizabeth Goldfarb, associate research scientist at the Yale Stress Center and lead author of the study.

Goldfarb and co-authors, including senior author Rajita Sinha, the Foundations Fund Professor of Psychiatry, conducted a series of fMRI scans of subjects who were asked to quantify their stress levels when presented with troubling images.

The study reveals that neural connections emanating from the hippocampus when viewing these images reached not only areas of the brain associated with physiological stress responses, but also the dorsal lateral frontal cortex, an area of the brain involved in higher cognitive functions and regulation of emotions. The Yale team found that when neural connections between the hippocampus and frontal cortex were stronger, subjects reported feeling less stressed by the troublesome images.

Conversely, subjects reported feeling more stressed when the neural network between the hippocampus and hypothalamus was more active.

The authors note there is also evidence from other studies that those suffering from mental health disorders such as anxiety may have difficulty receiving calming feedback from the frontal cortex in times of stress.

These findings may help us tailor therapeutic intervention to multiple targets, such as increasing the strength of the connections from the hippocampus to the frontal cortex or decreasing the signaling to the physiological stress centers, said Sinha, who is also a professor in Yales Child Study Center and neuroscience department.

All study subjects were healthy, she said, and in some cases their responses during the experiment seemed to be adaptive in other words, the network connections with the frontal cortex became stronger as the subjects were exposed to the stressful images. Sinha and Goldfarb speculated that these subjects might be accessing memories that help moderate their response to stressful images.

Similar to recent findings that remembering positive experiences can lower the bodys stress response, our work suggests that memory-related brain networks can be harnessed to create a more resilient emotional response to stress, Goldfarb said.ReferenceGoldfarb et al. (2020). Hippocampal seed connectome-based modeling predicts the feeling of stress. Nature Communications. DOI: https://doi.org/10.1038/s41467-020-16492-2

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Link:
Researchers Identify Where Stress "Lives" in the Brain - Technology Networks

COVID-19 Impact on Neuroscience Market Marked US$ 520 Mn in forecast Year 2025 – Medic Insider

New York City, United States With the outbreak of COVID-19 in worldwide and stipulated lockdown, the healthcare sector is witnessing an unprecedented slowdown as per EY-FICCI study titled, COVID-19 impact assessment for healthcare sector and key financial measures recommendations for the sector. The study is predicated on an assessment of healthcare players within the country to assess the economic impact of the COVID-19 pandemic and provides recommendations on the fiscal stimulus measures it needs within the coming months.

With healthy CAGR of 6.4%, the globalneuroscience marketis likely to grow from US$ 301.6 Mn in 2016 to US$ 520.8 Mn by 2025 end. This growth is mainly fuelled by advancement in neuroimaging and increasing R & D in neuroinformatics. Neuroscience Market: Global Industry Analysis (2012-2016)and Forecast (2017-2025),is the new publication of Persistence Market Research that focuses on merger and acquisition, strategic collaborations and technology, and technology transfer agreements, which play a vital role in the global neuroscience market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/13390

Company Profiles

North America and Europe are expected to dominate the global neuroscience market in the assessed period of 8-years that is between 2017 and 2025.

Global Neuroscience Market: Relevance and Impact of Factors

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/13390

Global Neuroscience Market: Forecast by Component Type

On the basis of component type, the global neuroscience market is segmented into instrument, software and services. Instrument segmented is sub-segmented into MRI imaging systems and neuromicroscopy, while services segmented divided into consulting services, installation services and maintenance services.

Instrument segment dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. Instrument segment is the most attractive segment, with attractiveness index of 2.6 over the forecast period.

Instrument segment was valued at US$ 221.6 Mn in 2016 and is projected to be valued at US$ 408.1 Mn in 2025 growing at a CAGR of 7.2% during the forecast period. This segment is expected to accounts for high revenue contribution to the global neuroscience market as compared to software and services segments over the forecast period.

Software segment is expected to be the second most lucrative segment in the global neuroscience market, with attractiveness index of 0.3 during the forecast period. This segment was accounted for 15.4% value share in 2017 which is expected to drop down to 12.9 % revenue share in 2025.

Global Neuroscience Market: Forecast by End User

On the basis of end user, global neuroscience market is segmented into hospitals, diagnostic laboratories, research institutes, and academic institutes.

Diagnostics laboratory segment is expected to be the second most lucrative segment in the global neuroscience market by 2025 end. However, in terms of CAGR and revenue share, hospitals segment is expected to lead he market throughout the estimated period. In 2025, hospital segment is likely to grab 40.2% market share in 2025, expanding at a robust CAGR of 7.3% during the estimated period.

Research institutes segment is expected to be the least attractive segment in the global neuroscience market, with attractiveness index of 0.7 during the forecast period.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/13390

Global Neuroscience Market: Forecast by Region

On the basis of region, global neuroscience market is segmented into North America, Latin America, Europe, APAC and MEA. North America dominated the global neuroscience market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period.

North America is projected to be the most attractive market with attractiveness index of 2.3 during the forecast period. Europe is expected to be the second most lucrative market, with attractiveness index of 1.1 respectively during the forecast period.

Europe Neuroscience market accounted for 23.9% share in 2017 and is projected to account for 23.1% share by 2025 end.

Explore Extensive Coverage of PMR`sLife Sciences & Transformational HealthLandscape

Feminine Hygiene Product Market Feminine Hygiene Products Market Segmented By Sanitary Pads/Napkins, Tampons, Panty Liners, Menstrual Cups, and Feminine Hygiene Wash.For More Information

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish KoltePersistence Market ResearchAddress 305 Broadway, 7th FloorNew York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

See the original post here:
COVID-19 Impact on Neuroscience Market Marked US$ 520 Mn in forecast Year 2025 - Medic Insider